About the Journal

Providing a fully open-access, internationally peer-reviewed platform, iMed is dedicated to intelligent medicine—the integration of digital technologies, artificial intelligence, and medical science to create smarter, more responsive healthcare systems. The journal focuses on how intelligent systems, data-driven approaches, and connected devices are transforming diagnosis, treatment, monitoring, and health system management. iMed recognizes that the future of medicine is increasingly intelligent, proactive, and personalized, and encourages scholarship addressing technological innovation, clinical integration, patient outcomes, and the ethical and societal implications of intelligent healthcare.

Focus and Scope

iMed covers intelligent systems and technologies applied to healthcare, including AI-driven diagnostics, smart devices, digital therapeutics, intelligent monitoring, and data-driven clinical decision support. Topics include but are not limited to:

  • AI-assisted clinical diagnosis and prognosis
  • Smart wearables and remote patient monitoring
  • Intelligent imaging and computational pathology
  • Digital health platforms and mobile health applications
  • Clinical decision support systems
  • Predictive analytics for patient risk stratification
  • Virtual health assistants and conversational AI in healthcare
  • Hospital automation and smart health infrastructure
  • Telemedicine and virtual care delivery
  • Intelligent electronic health records
  • Drug safety monitoring and pharmacovigilance
  • Federated learning and privacy-preserving health AI
  • Human-computer interaction in clinical settings
  • Regulatory and ethical aspects of intelligent medicine
  • Cost-effectiveness and health economics of smart technologies

iMed welcomes original research, reviews, case studies, perspectives, and opinions that advance intelligent medicine, and encourages interdisciplinary approaches bridging medicine, computer science, biomedical engineering, data science, and health policy—particularly technologies demonstrating measurable improvements in care quality or outcomes.

iMedOpen Access

iMed

iMed is owned by Sin-Chn Scientific Press Pte. Ltd.